Literature DB >> 19761844

Human bone marrow-derived stromal cells show highly efficient stress-resistant adipogenesis on denatured collagen IV matrix but not on its native counterpart: implications for obesity.

Joshua Mauney1, Vladimir Volloch.   

Abstract

Collagen IV is the major matrix component associated with differentiating adipocytes in adipose tissues, and the understanding of its contribution in adipogenic differentiation could be important for elucidation of mechanisms and processes driving the obesity. Therefore, in the light of our previous findings of differential effects of structural conformation of collagen I matrix on differentiation of bone marrow stromal cells, we investigated whether similar phenomenon occurs on collagen IV matrix in native and denatured structural states. The results of the present study show that native collagen IV is unsupportive of adipogenic differentiation and very little if any adipogenesis occurs on this matrix in the presence of adipogenic stimuli. In sharp contrast to native collagen IV, the same matrix in denatured structural state drives highly efficient adipogenic differentiation suggesting that it might be the major driver of adipogenesis in adipose tissues and that the ratio of native to denatured matrix might regulate the intensity of adipogenesis and possibly underlies the obesity. In contrast to observations that adipogenesis on denatured collagen I (collagen I is the major matrix component in musculoskeletal tissues) is suppressed by stress, adipogenesis on denatured collagen IV appears to be stress-resistant suggesting an explanation for the observed ineffectiveness of physical exercise, i.e. mechanical stress, in the reduction of adipose tissues. The obesity was shown to be associated with overproduction of MMPs and decline in levels of TIMPs. Such a shift in MMP/TIMP balance was considered a consequence of the pathology. In the light of the present study, however, this shift might constitute the primary source of the decease. The findings of the present study suggest strategies for the treatment of obesity, raise significant questions and indicate directions for further experimentation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19761844      PMCID: PMC6817336          DOI: 10.1016/j.matbio.2009.09.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  42 in total

1.  Cell differentiation by mechanical stress.

Authors:  Gregory H Altman; Rebecca L Horan; Ivan Martin; Jian Farhadi; Peter R H Stark; Vladimir Volloch; John C Richmond; Gordana Vunjak-Novakovic; David L Kaplan
Journal:  FASEB J       Date:  2001-12-28       Impact factor: 5.191

2.  Phosphorylation of serine 230 promotes inducible transcriptional activity of heat shock factor 1.

Authors:  C I Holmberg; V Hietakangas; A Mikhailov; J O Rantanen; M Kallio; A Meinander; J Hellman; N Morrice; C MacKintosh; R I Morimoto; J E Eriksson; L Sistonen
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

3.  Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.

Authors:  Joshua R Mauney; Vladimir Volloch; David L Kaplan
Journal:  Biomaterials       Date:  2005-11       Impact factor: 12.479

4.  Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity.

Authors:  Erik Maquoi; Carine Munaut; Alain Colige; Désiré Collen; H Roger Lijnen
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

Review 5.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

6.  Repression of the heat shock factor 1 transcriptional activation domain is modulated by constitutive phosphorylation.

Authors:  M P Kline; R I Morimoto
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

7.  Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.

Authors:  Cezary Marcinkiewicz; Paul H Weinreb; Juan J Calvete; Dariusz G Kisiel; Shaker A Mousa; George P Tuszynski; Roy R Lobb
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

8.  Reduced thermotolerance in aged cells results from a loss of an hsp72-mediated control of JNK signaling pathway.

Authors:  V Volloch; D D Mosser; B Massie; M Y Sherman
Journal:  Cell Stress Chaperones       Date:  1998-12       Impact factor: 3.667

9.  Progression of human bone marrow stromal cells into both osteogenic and adipogenic lineages is differentially regulated by structural conformation of collagen I matrix via distinct signaling pathways.

Authors:  Josh Mauney; Vladimir Volloch
Journal:  Matrix Biol       Date:  2009-04-16       Impact factor: 11.583

10.  Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.

Authors:  Carine Chavey; Bernard Mari; Marie-Noëlle Monthouel; Stéphanie Bonnafous; Patrick Anglard; Emmanuel Van Obberghen; Sophie Tartare-Deckert
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

View more
  11 in total

1.  Tailored integrin-extracellular matrix interactions to direct human mesenchymal stem cell differentiation.

Authors:  Jessica Ellen Frith; Richard James Mills; James Edward Hudson; Justin John Cooper-White
Journal:  Stem Cells Dev       Date:  2012-05-31       Impact factor: 3.272

Review 2.  Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective.

Authors:  Flora Ippoliti; Nicoletta Canitano; Rita Businaro
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-18       Impact factor: 4.147

3.  Why cellular stress suppresses adipogenesis in skeletal tissue, but is ineffective in adipose tissue: control of mesenchymal cell differentiation via integrin binding sites in extracellular matrices.

Authors:  Vladimir Volloch; Bjorn R Olsen
Journal:  Matrix Biol       Date:  2013-06-18       Impact factor: 11.583

4.  Laminin production and basement membrane deposition by mesenchymal stem cells upon adipogenic differentiation.

Authors:  Ariel Noro; Tarvo Sillat; Ismo Virtanen; Sulev Ingerpuu; Nils Bäck; Yrjö T Konttinen; Matti Korhonen
Journal:  J Histochem Cytochem       Date:  2013-07-30       Impact factor: 2.479

5.  Matrix remodeling as stem cell recruitment event: a novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix.

Authors:  Joshua Mauney; Bjorn R Olsen; Vladimir Volloch
Journal:  Matrix Biol       Date:  2010-09-07       Impact factor: 11.583

Review 6.  Fat fibrosis: friend or foe?

Authors:  Ritwik Datta; Michael J Podolsky; Kamran Atabai
Journal:  JCI Insight       Date:  2018-10-04

7.  Adult human bone marrow stromal cells regulate expression of their MMPs and TIMPs in differentiation type-specific manner.

Authors:  Joshua Mauney; Vladimir Volloch
Journal:  Matrix Biol       Date:  2009-09-17       Impact factor: 11.583

8.  Basement membrane collagen type IV expression by human mesenchymal stem cells during adipogenic differentiation.

Authors:  Tarvo Sillat; Riste Saat; Raimo Pöllänen; Mika Hukkanen; Michiaki Takagi; Yrjö T Konttinen
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

Review 9.  The secretion profile of mesenchymal stem cells and potential applications in treating human diseases.

Authors:  Yuyi Han; Jianxin Yang; Jiankai Fang; Yipeng Zhou; Eleonora Candi; Jihong Wang; Dong Hua; Changshun Shao; Yufang Shi
Journal:  Signal Transduct Target Ther       Date:  2022-03-21

10.  ECM microenvironment unlocks brown adipogenic potential of adult human bone marrow-derived MSCs.

Authors:  Michelle H Lee; Anna G Goralczyk; Rókus Kriszt; Xiu Min Ang; Cedric Badowski; Ying Li; Scott A Summers; Sue-Anne Toh; M Shabeer Yassin; Asim Shabbir; Allan Sheppard; Michael Raghunath
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.